EU and US could reach trade deal this weekend - Reuters
Investing.com - Viatris Inc (NASDAQ:VTRS) reported first-quarter earnings on Thursday that fell short of analyst expectations, while reaffirming its full-year 2025 guidance.
The company’s stock rose 1.9% following the announcement.
The global healthcare company reported adjusted earnings per share of $0.50, missing the analyst consensus of $0.51 by $0.01.
Revenue for the quarter came in at $3.25 billion, below the expected $3.33 billion and down 11% YoY on a reported basis.
However, on a divestiture-adjusted operational basis, revenue declined only 2% YoY.
Despite the miss, Viatris reaffirmed its full-year 2025 guidance, projecting adjusted EPS of $2.16-$2.30 and revenue of $13.5-14 billion.
The midpoint of both ranges is slightly above current analyst consensus estimates.
The company attributed the revenue decline primarily to the negative impact from its Indore facility. Excluding this impact, Viatris said total revenues would have increased 2% on a divestiture-adjusted operational basis compared to the first quarter of 2024.
Viatris reported a U.S. GAAP net loss of $3.0 billion for the quarter, largely due to a non-cash goodwill impairment charge of $2.9 billion.
The company generated $535 million in cash from operations and $493 million in free cash flow during the quarter.
Viatris maintains its commitment to delivering approximately $450 million to $550 million in new product revenues for 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.